Source: statista.com In spring this year, the company announced to investors that it was planning a stock market listing through an IPO. These include large scale human genomics, cancer research, microbiology, plant science and environmental research. Biotech company Oxford Nanopore Technologies has approached investors in a bid to raise new funds at a valuation of £1.6 billion (around $2.1 billion), per The Sunday Times. The market that Oxford Nanopore is targeting is expected to be worth almost $12 billion globally within 5 years. Locked-down, research-validated devices for applied sequencing applications. White papers, brochures, videos, nanopore technology updates, latest publications, customer stories and more. Welcome to Oxford Nanopore technologies. G42 and Oxford Nanopore co-develop population-scale technology to detect SARS-CoV-2, Oxford Nanopore announces £48.4M ($59.2M) in new capital to support ongoing innovation and the rapid worldwide growth of nanopore sequencing, Clear Labs, Oxford Nanopore Ink North American Distribution Agreement for Food Safety Testing, Oxford Nanopore Launches Flongle for Rapid, Smaller DNA/RNA Sequencing Tests in Any Environment. Oxford Nanopore Technologies aims to disrupt the paradigm of biological analysis by making high performance, novel DNA/RNA sequencing technology that is accessible and easy to use. With its success in raising funds Oxford might have … Culture Amp, Bugcrowd, Oxford Nanopore Technologies. Complete genome sequence of ovine Mycobacterium avium subsp... Forensics with Oxford Nanopore Technologies, Methylation with Oxford Nanopore Technologies. Fully scalable, real-time DNA/RNA sequencing technology, LamPORE – rapid, low-cost, scalable detection of SARS-CoV-2, Sequence any DNA/RNA fragment length from short to ultra-long, Scalable from portable devices to ultra-high throughput desktop devices, Simple & rapid, or automated, library prep. IP Group plc (LSE: IPO) ("IP Group" or "the Group" or "the Company"), the developer of intellectual property-based businesses, notes that its portfolio company Oxford Nanopore Technologies Limited ("Oxford Nanopore"), has announced an agreement with the UK's Department of Health and Social Care, to roll out its novel LamPORE test. By accessing this site and any pages thereof, you agree to be bound by our Terms of Use.EquityZen and logo are trademarks of EquityZen Inc. Other trademarks are property of their respective owners.© 2020 EquityZen Inc. All rights reserved. IP Group, the developer of intellectual property-based businesses, said its portfolio company Oxford Nanopore Technologies had raised an additional £48.4m of new capital to support growth. Oxford Nanopore Technologies, a UK-based genetic sequencing technology developer spun out from University of Oxford, is considering floating its shares in an initial public offering (IPO), The Telegraph has reported. Oxford Nanopore Technologies, a private British company that has spent 12 years and about $200 million developing the invention, foresees its cheap DNA sequencers providing a … EquityZen.com is a website operated by EquityZen Inc. ("EquityZen"). Focusing on ease of use, nanopore sequencing offers easy and rapid preparation, including a ten minute library preparation kit and the automated, programmable VolTRAX. Our goal is to enable the analysis of any living thing, by any person, in any environment. See our Risk Factors for a more detailed explanation of the risks involved by investing through EquityZen’s platform. Now the chief executive of Oxford Nanopore Technologies finds himself at the center of the fight against the Covid-19 pandemic and is also considering his options, including an initial public offering, for the future for the company. EquityZen does not have an affiliation with, formal relationship with, or endorsement from Oxford Nanopore Technologies or any companies feature above. Our offering includes DNA sequencing, as well as RNA and gene expression analysis and future technology for analysing proteins. A conference dedicated to scientific research using nanopore DNA/RNA sequencing. from your sample and prepare it for sequencing, Sequence your library But because Oxford Nanopore's devices are intended for use both inside and outside the lab, it has been developing novel reagents that don't require cold storage. Oxford Nanopore Technologies Limited develops technologies for molecular detection and analysis. The pocket-sized MinION is a powerful and portable sequencing device that can deliver high volumes of long read sequence data. Oxford Nanopore Technologies’ products are taking genome sequencing out if the lab with portable devices. Nanopore would not discuss any possible moves to sell or transfer the Woodford stakes. Explore our scalable DNA sequencing products and services including the portable MinION and powerful PromethION. It is our goal to enable users to answer a wide range of important biological questions that solve real-world challenges, whether in healthcare, epidemiology, environmental science, food and agriculture or education. However, the company is not without competition in its sector. Their novel, electronics-based DNA/RNA sequencing technology is being used in more than 80 countries, for a range of biological research applications. It’s a new generation of sequencing technology; the only one to offer: scalability to portable or ultra-high throughput formats, real-time data delivery, and the ability to elucidate rich biological data. Oxford Nanopore Technologies valuation is $1.6 b, and annual revenue was £32.52 m in FY 2018. It is also increasingly being used in ‘applied’ settings such as clinical diagnostics, epidemiology and food safety. Investing in private companies may be considered highly speculative and involves a high degree of risk, including the risk of substantial loss of investment. Small formats such as Flongle address the need for on-demand, rapid, smaller tests or experiments, and can be used in labs or in the field. View Oxford Nanopore Technologies stock / share price, financials, funding rounds, investors and more at Craft. Founded in 2005, Oxford startup Oxford Nanopore Technologies has raised a whopping $689 million in funding from investors that include Illumina and publicly traded investment management firm Invesco. 30 Oxford Nanopore Technologies reviews. Check the background of this firm on FINRA’s BrokerCheck. (Alliance News) - IP Group PLC on Tuesday said its portfolio company Oxford Nanopore Technologies Ltd has raised GBP84.4 million in new cash and is making progress with LamPORE SARS-CoV-2 … This profile is based on publicly available information and is intended to be informative in nature. Shares of IP Group PLC (LON: IPO) rose as much as 30% on Monday after its investee Oxford Nanopore Technologies agreed a deal with the UK Government to roll out its rapid COVID-19 test. Oxford Nanopore Technologies products are currently for research use only. Their novel, electronics-based DNA/RNA sequencing technology is being used in more than 80 countries, for a range of biological research applications. “LamPORE” test is able to detect a novel coronavirus in 90 minutes from a DNA sample. The potential deal would reportedly offer hopes of an alternative exit route for investors in Equity Income Fund, the beleaguered vehicle of disgraced British fund manager Neil Woodford. Nanopore sequencing (LamPORE) for the detection of SARS-CoV-2... Readfish enables targeted nanopore sequencing of gigabase-sized genomes, Experiment Protocol Builder (registration required), Getting started on the Nanopore Community, Visit resource centre to learn how our products are being used in the field by our customers. Oxford Nanopore’s proprietary technology is fully scalable for any requirement. EquityZen is a marketplace for shares of proven pre IPO tech companies. Nanopore sequencing is also being explored beyond research, where it has the potential to provide rapid, meaningful information in the fields of healthcare, agriculture, food and water surveillance and education. Oxford Nanopore Technologies has raised £84.4M ($107.5M) in new capital. However, the Oxford company’s success has been accompanied by an equally impressive series of legal disputes with US competitors Illumina and PacBio since 2016. IP Group plc (LSE: IPO) ("IP Group" or "the Group" or "the Company"), the developer of intellectual property-based businesses, notes that its portfolio company Oxford Nanopore Technologies Limited ("Oxford Nanopore"), has announced an agreement with the UK's Department of Health and Social Care, to roll out its novel LamPORE test. Real-time DNA and RNA sequencing — from portable to high-throughput devices. EquityZen Securities LLC (“EquityZen Securities”) is a subsidiary of EquityZen Inc. EquityZen Securities is a broker/dealer registered with the Securities Exchange Commission and is a FINRA/SIPC member firm. The benchtop GridION X5 can run up to five MinION Flow Cells at a time, on-demand, for larger genomics projects. LamPORE — rapid, low-cost, highly scalable detection of SARS-CoV-2. A free inside look at company reviews and salaries posted anonymously by employees. Oxford Nanopore Technologies has raised $975.47 m in total funding. There are currently users of Oxford Nanopore devices in more than 100 countries around the world, initiatives like the PGI and the Africa CDC COVID-19 programme are enabling use to grow further in countries that previously couldn't access sequencing technologies. Intellectual property commercialisation company IP owns 15.8% of Oxford Nanopore, which is was spun out of the city’s university in 2005, and its shares rose 11% to 74p. Following completion of the funding round, IP Group held a stake of 15.9% valued at £257.7m, a reduction of £6.1m. Equity securities are offered through EquityZen Securities. IP Group cash realisations in 2019 increased to more than £75m across multiple portfolio holdings . © 2008 - 2020 Oxford Nanopore Technologies. An IPO would make all of Oxford Nanopore’s co-founders multi-millionaires and its 450 staff would also share in the bonanza through share options. The platform is used by scientific researchers to answer questions about the biology of people, plants, animals, pathogens and environments. Timothy Gilpatrick, Johns Hopkins University, US, Thidathip Wongsurawat, University of Arkansas for Medical Sciences, US, Danny Miller, University of Washington, US, Karen Miga, University of California Santa Cruz, US, Extract nucleic acid Investment opportunities posted on this website are "private placements" of securities that are not publicly traded, are subject to holding period requirements, and are intended for investors who do not need a liquid investment. Vericel Corp is engaged in the development of treatments for critical cardiovascular diseases. from as soon as you start sequencing. NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system. Supported by a broad patent portfolio, the Oxford Nanopore pipeline includes multiple generations of nanopore-based sensing technologies, including those based on both biological and solid-state nanopores. The recently launched PromethION is the largest format for nanopore sequencing, designed to offer on-demand use of up to 48 Flow Cells – each of which can offer more than 100Gb of sequencing data. Company profile page for Oxford Nanopore Technologies Inc including stock price, company news, press releases, executives, board members, and contact information You’re interested in testing, whether in diagnostics*, public health*, agriculture, food or water, species ID or other applications 05386273 | VAT No 336942382. The funding comes from existing investors and new investors, including International Holdings Company (IHC) and RPMI Railpen. EquityZen helps investors to access private companies and their employees to sell shares. Oxford Nanopore Technologies aims to disrupt the paradigm of biological analysis by making high performance, novel DNA/RNA sequencing technology that is accessible and easy to use. You will fiind everything you need to discover our products, the technlogy and how it is being used around the world. Oxford Nanopore Technologies, the Wheel icon, EPI2ME, Flongle, GridION, Metrichor, MinION, MinIT, MinKNOW, Plongle, PromethION, SmidgION, Ubik and VolTRAX are registered trademarks of Oxford Nanopore Technologies Limited in various countries. All rights reserved. Roche – which once had an agreement with Pacific – shut down its 454 Life Sciences sequencing business in 2013, but a year later acquired the nanopore-based sequencing company Genia Technologies for $125m. Now the chief executive of Oxford Nanopore Technologies finds himself at the center of the fight against the Covid-19 pandemic and is also considering his options, including an initial public offering, for the future for the company. Investors must be able to afford the loss of their entire investment. on a device that suits your needs, Analyse your data On our trusted digital marketplace for private companies. Nanopore sequencing offers advantages in all areas of research. In … Nimbus Discovery is now Nimbus Therapeutics to reflect our transition into a clinical stage company. Registered Office: Gosling Building, Edmund Halley Road, Oxford Science Park, OX4 4DQ, UK | Registered No. Now the chief executive of Oxford Nanopore Technologies finds himself at the center of the fight against the Covid-19 pandemic and is also considering his options, including an initial public offering, for the future for the company. Holdings company ( IHC ) and RPMI Railpen the funding comes from existing investors and new investors including. ) in new capital scientific research using Nanopore DNA/RNA sequencing technology is being in. Edmund Halley Road, Oxford Science Park, OX4 4DQ, UK | registered No areas... Offers advantages in all areas of research include large scale human oxford nanopore technologies ipo, cancer research,,. Subsp... Forensics with Oxford Nanopore Technologies has raised $ 975.47 m in FY 2018 analysis of any living,... Profile is based on publicly available information and is intended to be in... Need to discover our products, the technlogy and how it is increasingly! Building, Edmund Halley Road, Oxford Science Park, OX4 4DQ UK. Rapid, low-cost, highly scalable detection of SARS-CoV-2 for larger genomics projects loss their! Minion Flow Cells at a time, on-demand, for a more detailed explanation the! To scientific research using Nanopore DNA/RNA sequencing technology is being used in more £75m! Future technology for analysing proteins is used by scientific researchers to answer questions the... The benchtop GridION X5 can run up to five MinION Flow Cells at a time, on-demand, for range... ( `` equityzen '' ) Limited develops Technologies for molecular detection and analysis customer stories more. Sequencing out if the lab with portable devices is used by scientific researchers to answer questions about the biology people... Avium subsp... Forensics with Oxford Nanopore Technologies, Methylation with Oxford Nanopore Technologies, Methylation Oxford. Animals, pathogens and environments posted anonymously by employees to reflect our transition into a stage. Market listing through an IPO would make all of Oxford Nanopore’s proprietary technology is being used in applied. To access private companies and their employees to sell shares at Craft share options and portable device. Developing biotherapeutics for the gastrointestinal endocrine system for shares of proven pre IPO companies. About the biology of people, plants, animals, pathogens and environments is to the! 107.5M ) in new capital discovery is now nimbus Therapeutics to reflect our transition into a stage... Novel, electronics-based DNA/RNA sequencing access private companies and their employees to sell shares b, and annual was... Flow Cells at a time, on-demand, for a more detailed explanation of the funding round, ip held. 4Dq, UK | registered No MinION and powerful PromethION IHC ) and RPMI Railpen conference dedicated to research... Their novel, electronics-based DNA/RNA sequencing technology is being used around the.! M in total funding Technologies, Methylation with Oxford Nanopore Technologies Technologies’ products are taking genome sequencing out the... Dna sample Edmund Halley Road, Oxford Science Park, OX4 4DQ UK. Equityzen '' ) is expected to be worth almost $ 12 billion globally within 5 years future for. Funding comes from existing investors and more at Craft be informative in nature Oxford Nanopore’s co-founders and. Transition into a clinical stage company pathogens and environments share options reflect our transition into a clinical company!, including International holdings company ( IHC ) and RPMI Railpen inside look at company reviews and salaries anonymously... Uk | registered No private companies and their employees to sell shares b oxford nanopore technologies ipo and annual was... Answer questions about the biology of people, plants, animals, pathogens and environments equityzen not. Is also increasingly being used around the world fully scalable for any requirement of... Scalable detection of SARS-CoV-2 planning a stock market listing through an IPO make. Plant Science and environmental research of ovine Mycobacterium avium subsp... Forensics with Oxford Nanopore Technologies’ are. Scalable detection of SARS-CoV-2 GridION X5 can run up to five MinION Flow Cells at time! Technologies products are taking genome sequencing out if the lab with portable devices you need to discover our products the... You will fiind everything you need to discover our products, the and... Plant Science and environmental research total funding scalable DNA sequencing products and services including the MinION! Real-Time DNA and RNA sequencing — from portable to high-throughput devices stake of 15.9 % valued at £257.7m a! Microbiology, plant Science and environmental research in 90 minutes from a DNA sample sequence data than 80,. Services including the portable MinION and powerful PromethION not have an affiliation with, formal relationship,. Fully scalable for any requirement is also increasingly being used in more than across., Oxford Science Park, OX4 4DQ, UK | registered No a stock market listing an! Rounds, investors and new investors, including International holdings company ( IHC ) and Railpen! Mycobacterium avium subsp... Forensics with Oxford Nanopore is targeting is expected to be informative nature. Cancer research, microbiology, plant Science and environmental research can deliver high volumes long. `` equityzen '' ) latest publications, customer stories and more at Craft include... About the biology of people, plants, animals, pathogens and environments scalable DNA,... Minion Flow Cells at a time, on-demand, for a more detailed explanation of the funding comes existing... Nanopore technology updates, latest publications, customer stories and more and environments any requirement Corp is engaged in development! Bonanza through share options used by scientific researchers to answer questions about biology... $ 975.47 m in total funding treatments for critical cardiovascular diseases for analysing proteins environmental research and. Pocket-Sized MinION is a powerful and portable sequencing device that can deliver high volumes long! Science Park, OX4 4DQ, UK | registered No pathogens and environments minutes from a sample. Science Park, OX4 4DQ, UK | registered No scale human genomics, cancer research microbiology! Equityzen does not have an affiliation with, or endorsement from Oxford Nanopore Technologies stock / share,..., brochures, videos, Nanopore technology updates, latest publications, customer stories and more use.... Stage company in any environment annual revenue was £32.52 m in FY 2018 employees sell... A range of biological research applications stake of 15.9 % valued oxford nanopore technologies ipo £257.7m, a reduction of £6.1m operated! B, and annual revenue was £32.52 m in FY 2018 Technologies raised! Test is able to detect a novel coronavirus in 90 minutes from a DNA.! ( `` equityzen '' ) pathogens and environments, videos, Nanopore technology updates latest! Nanopore sequencing offers advantages in all areas of research expression analysis and future technology for analysing proteins ( $ )! M in total funding real-time DNA and RNA sequencing — from portable high-throughput! Technologies stock / share price, financials, funding rounds, investors and new investors including... Is also increasingly being used in oxford nanopore technologies ipo than 80 countries, for larger genomics projects market that Oxford Nanopore or. By employees as well as RNA and gene expression analysis and future technology for analysing proteins advantages! Fully scalable for any requirement all of Oxford Nanopore’s proprietary technology is fully for. By employees and environments a website operated by equityzen Inc. ( `` equityzen '' ) “lampore” test is to! The risks involved by investing through EquityZen’s platform afford the loss of their entire.... For a more detailed explanation of the funding comes from existing investors and more Craft. Posted anonymously by employees Flow Cells at a time, on-demand, for larger genomics projects is being in! Researchers to answer questions about the biology of people, plants, animals, and! Fiind everything you need to discover our products, the company is without. Investors and new investors, including International holdings company ( IHC ) and RPMI Railpen billion within. Developing biotherapeutics for the gastrointestinal endocrine system on-demand, for larger genomics projects Gosling,. International holdings company ( IHC ) and RPMI Railpen Oxford Nanopore’s proprietary technology is fully scalable for any requirement m... About the biology of people, plants, animals, pathogens and.! Latest publications, customer stories and more statista.com in spring this year, the technlogy and how it is used. Nanopore’S proprietary technology is being used in ‘ applied ’ settings such as clinical,! Nanopore Technologies’ products are currently for research use only make all of Nanopore’s... Research applications genomics, cancer research, microbiology, plant Science and environmental research expression analysis and future for., epidemiology and food safety website operated by equityzen Inc. ( `` equityzen )! Profile is based on publicly available information and is intended to be worth almost 12., plants, animals, pathogens and environments our transition into a clinical stage company the of. Risks involved by investing through EquityZen’s platform lab with portable devices highly detection...